Capital Investment Advisors’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-5,209
Closed -$923K 514
2020
Q1
$923K Sell
5,209
-104
-2% -$19.6K 0.06% 205
2019
Q4
$1.02M Sell
5,313
-74
-1% -$13.3K 0.05% 231
2019
Q3
$907K Buy
5,387
+30
+0.6% +$4.89K 0.05% 235
2019
Q2
$897K Sell
5,357
-5
-0.1% -$692 0.05% 239
2019
Q1
$785K Sell
5,362
-325
-6% -$47.1K 0.05% 243
2018
Q4
$760K Sell
5,687
-255
-4% -$41.8K 0.05% 239
2018
Q3
$1.13M Hold
5,942
0.07% 201
2018
Q2
$991K Buy
5,942
+60
+1% +$9.63K 0.06% 215
2018
Q1
$990K Hold
5,882
0.06% 213
2017
Q4
$962K Sell
5,882
-506
-8% -$90.8K 0.06% 218
2017
Q3
$1.31M Sell
6,388
-21
-0.3% -$4.88K 0.09% 171
2017
Q2
$1.56M Buy
6,409
+67
+1% +$15.7K 0.11% 153
2017
Q1
$1.51M Buy
6,342
+60
+1% +$14K 0.11% 157
2016
Q4
$1.32M Buy
6,282
+200
+3% +$41.4K 0.11% 166
2016
Q3
$1.4M Sell
6,082
-400
-6% -$97.7K 0.12% 157
2016
Q2
$1.5M Buy
+6,482
New +$1.49M 0.14% 138
2015
Q3
Sell
-6,532
Closed -$1.98M 402
2015
Q2
$1.98M Buy
+6,532
New +$1.95M 0.21% 110
2014
Q2
Sell
-7,065
Closed -$1.45M 405
2014
Q1
$1.45M Sell
7,065
-35
-0.5% -$6.93K 0.18% 131
2013
Q4
$1.19M Buy
+7,100
New +$1.11M 0.16% 144

Other funds holding AGN

Capital Investment Advisors's AGN Position: Q2 2020 in Review

Capital Investment Advisors sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 5,209 shares — an estimated $923K sold.

Capital Investment Advisors first reported a position in AGN in Q4 2013 and held it in 19 quarters. The position peaked at $1.98M in Q2 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Capital Investment Advisors reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Capital Investment Advisors sold 5,209 Allergan plc shares in Q2 2020, an estimated $923K.
  • Capital Investment Advisors first reported a position in Allergan plc in Q4 2013 and held it in 19 quarters.
  • Capital Investment Advisors's Allergan plc position peaked at $1.98M in Q2 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Capital Investment Advisors's 13F filing for Q2 2020, filed 20 Jul 2020.